Eleuthero, or Siberian ginseng: what clinical studies on endurance and fatigue really demonstrated and which medications the plant interacts with.

Oyster mushroom, slippery jack, and honey fungus from Polish forests alongside reishi. We check which claims about Polish mushrooms are backed by research and which are repeated legends.

What is known about difficult experiences after psychedelics, what support principles are described by the Zendo Project, and how to recognize when medical help is needed.

Ibogaine prolongs the QTc interval, and Tabernanthe iboga is classified in Poland as a Group I-N narcotic. What measurements showed, the research registry, and the Stanford study.

Where does dry mouth after cannabis come from, on which species the mechanism was measured, how often it affects people, and when the symptom requires a visit to the dentist.

What is integration after a psychedelic experience, how many sessions do clinical trial protocols foresee, and which practices have real support in data.

Two small randomized studies, two different results. In the longer one, VO2max did not change at all. We check what was actually measured and on whom.

Does microdosing psilocybin and LSD work beyond the placebo effect? A review of studies with a control group, the issue of blinding, and the legal status in Poland.

Chinese magnolia vine and the liver, endurance, and medications. We check which data comes from humans and which from animals, and how schisandra alters drug concentrations.

One pilot study on 50 people, a decrease in TSH, and a whole range of unanswered questions. We check what can be inferred from this and what cannot.

The CoCoA study: 90 people over sixty, eight weeks, three doses of cocoa flavanols. What did the primary endpoint achieve and what did COSMOS not show.

Common yarrow has an EMA monograph based solely on traditional use. Check the four registered indications, contraindications, and time limits.